Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | KLK7 | P49862 | 1/20 | 0.38 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.38 |
| ▸ | CTSK | P43235 | 4/20 | 0.37 |
| ▸ | CTSS | P25774 | 1/20 | 0.37 |
| ▸ | ITGB3 | P05106 | 7/20 | 0.37 |
| ▸ | ITGA2B | P08514 | 7/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.35 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10190377 | 0.92 | MEN1 (0.40) | MEN1KMT2AGAAKLK7KLK5 | |
| SCHEMBL12604209 | 0.90 | MEN1 (0.48) | MEN1KMT2AGAAKLK7KLK5 | |
| SCHEMBL30895563 | 0.90 | MEN1 (0.48) | MEN1KMT2AGAAKLK7KLK5 | |
| SCHEMBL3754005 | 0.87 | TDP1 (0.48) | MEN1KMT2AGAAKLK7KLK5 | |
| SCHEMBL29400712 | 0.87 | TDP1 (0.48) | MEN1KMT2AGAAKLK7KLK5 | |
| SCHEMBL9931542 | 0.87 | TDP1 (0.48) | MEN1KMT2AGAAKLK7KLK5 | |
| SCHEMBL29693333 | 0.86 | KLK7 (0.36) | MEN1KMT2AGAAKLK7KLK5 | |
| SCHEMBL16076756 | 0.84 | MEN1 (0.49) | MEN1KMT2AGAAKLK7KLK5 | |
| SCHEMBL18791214 | 0.84 | ITGB3 (0.45) | KLK7KLK5CTSKCTSSITGB3 | |
| SCHEMBL6473963 | 0.84 | ITGB3 (0.45) | KLK7KLK5CTSKCTSSITGB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200299417-A1 | CHITOSAN-DERIVATIVE COMPOUNDS AND METHODS OF CONTROLLING MICROBIAL POPULATIONS | UNITED STATES GOVERNMENT | 2020-09-24 | — | — | US | disclosed |
| US-20180127518-A1 | CHITOSAN-DERIVATIVE COMPOUNDS AND METHODS OF CONTROLLING MICROBIAL POPULATIONS | UNITED STATES GOVERNMENT | 2018-05-10 | — | — | US | disclosed |
| US-9732164-B2 | Chitosan-derivative compounds and methods of controlling microbial populations | SYNEDGEN, INC. (US) | 2017-08-15 | — | — | US | disclosed |
| US-20160060362-A1 | CHITOSAN-DERIVATIVE COMPOUNDS AND METHODS OF CONTROLLING MICROBIAL POPULATIONS | UNITED STATES GOVERNMENT | 2016-03-03 | — | — | US | disclosed |
| US-9029351-B2 | Chitosan-derivative compounds and methods of controlling microbial populations | SYNEDGEN, INC. (US) | 2015-05-12 | — | — | US | disclosed |
| US-20140301955-A1 | CHITOSAN-DERIVATIVE COMPOUNDS AND METHODS OF CONTROLLING MICROBIAL POPULATIONS | SYNEDGEN, INC. (US) | 2014-10-09 | — | — | US | disclosed |
| US-8658775-B2 | Chitosan-derivative compounds and methods of controlling microbial populations | UNITED STATES GOVERNMENT | 2014-02-25 | — | — | US | disclosed |
| US-20120329753-A1 | CHITOSAN-DERIVATIVE COMPOUNDS AND METHODS OF CONTROLLING MICROBIAL POPULATIONS | UNITED STATES GOVERNMENT | 2012-12-27 | — | — | US | disclosed |
| US-8119780-B2 | Chitosan-derivative compounds and methods of controlling microbial populations | SYNEDGEN, INC. (US) | 2012-02-21 | — | — | US | disclosed |
| US-8119780-B2 | Chitosan-derivative compounds and methods of controlling microbial populations | SYNEDGEN, INC. (US) | 2012-02-21 | — | — | US | disclosed |
| US-20070281904-A1 | Chitosan-derivative compounds and methods of controlling microbial populations | UNITED STATES GOVERNMENT | 2007-12-06 | — | — | US | disclosed |
| US-20070281904-A1 | Chitosan-derivative compounds and methods of controlling microbial populations | UNITED STATES GOVERNMENT | 2007-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180127518-A1 | CHITOSAN-DERIVATIVE COMPOUNDS AND METHODS OF CONTROLLING MICROBIAL POPULATIONS | ARG1, NRDC, CHIA | MEN1 1385/4885KMT2A 2126/4885GAA 496/4885 |
| US-20120329753-A1 | CHITOSAN-DERIVATIVE COMPOUNDS AND METHODS OF CONTROLLING MICROBIAL POPULATIONS | ARG1, NRDC, CHIA | MEN1 1385/4885KMT2A 2126/4885GAA 496/4885 |
| US-20200299417-A1 | CHITOSAN-DERIVATIVE COMPOUNDS AND METHODS OF CONTROLLING MICROBIAL POPULATIONS | ARG1, NRDC, CHIA | MEN1 1385/4885KMT2A 2126/4885GAA 496/4885 |
| US-20070281904-A1 | Chitosan-derivative compounds and methods of controlling microbial populations | ARG1, NRDC, CHIA | MEN1 1385/4885KMT2A 2126/4885GAA 496/4885 |
| US-20140301955-A1 | CHITOSAN-DERIVATIVE COMPOUNDS AND METHODS OF CONTROLLING MICROBIAL POPULATIONS | ARG1, NRDC, CHIA | MEN1 1385/4885KMT2A 2126/4885GAA 496/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.